铝碳酸镁、艾司奥美拉唑联合治疗胃溃疡的价值

Experience of the Clinical Value of Hydrotalcite Combined With Esomeprazole Treatment Quality of Gastric Ulcer Healing

目的探究胃溃疡患者接受铝碳酸镁与艾司奥美拉唑联合治疗对其溃疡黏膜愈合质量的影响。方法选取我院收治的胃溃疡患者100例作为研究对象。将其随机分为两组。两组患者分别实施艾司奥美拉唑治疗以及艾司奥美拉唑与铝碳酸镁联合治疗。结果实验组疗效优于对照组,不良反应几率、复发率低于对照组,差异具有统计学意义(P<0.05)。结论胃溃疡患者接受铝碳酸镁与艾司奥美拉唑联合治疗的价值较高。

Objective To explore the acceptance of hydrotalcite and esomeprazole combined treatment effect on healing quality of ulcer mucosa in patients with gastric ulcer. Methods 100 cases of gastric ulcer were divided into two groups respectively, the implementation of esomeprazole therapy and combined therapy of esomeprazole and hydrotalcite. ResultsThe effect of the experimental group was better than that of the control group. The rate of adverse reaction and the rate of relapse were lower than that of the control group, the difference was statistically significant（P〈0.05）. Conclusion The higher value of gastric ulcer patients received combination therapy with esomeprazole of hydrotalcite.